President Donald Trump shocked a bipartisan group of lawmakers Wednesday when he called for a series of changes to current gun laws, including comprehensive background checks and age limits for buyers. And Florida Congressman Darren Soto told Cheddar that, if changes aren’t made, this will be a major issue come midterms. “This will absolutely be one of those litmus test issues that can really swing a lot of voters,” he said in an interview before the president’s comments. “We’re talking about our young people keeping up their energy until the November elections.” The latest developments come two weeks after the mass shooting at Marjory Stoneman Douglas High School. Survivors have sparked a nationwide #NeverAgain movement and even discussed gun control with high-profile Republican legislators, including Speaker of the House Paul Ryan and the commander-in-chief. Soto said this isn’t the first time one group has been able to effect change at the ballot. He pointed to Democrat Margaret Good, who won Florida’s 72nd House district, a usually Republican area, the day before the Parkland, Fla., shooting. “We saw that in the special election recently in Florida, that Republican women, suburban women who were independent, have come out in favor of Democrats,” he said. “They see that the Republicans aren’t willing to do anything to help protect our kids.” For the full interview, [click here](https://cheddar.com/videos/rep-darren-soto-speaker-ryans-gun-control-comments-a-real-shame).

Share:
More In Politics
Trump Hails Progress on Vaccine in First Remarks Since Loss
President Donald Trump has hailed developments in the race for a vaccine for the resurgent coronavirus. He delivered his first public remarks Friday since his defeat by President-elect Joe Biden, even as he refuses to concede the election.
Wall Street Shrugs, Stocks Rise Even as Trump Won't Concede
The reason for such calm is that Wall Street doesn't see Trump's anger, tweets or legal actions changing the results. And encouraging data about a potential COVID-19 vaccine has renewed investors' optimism even though virus cases are on the rise.
Load More